We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New FDA AI Tool Identifies AE Changes in Drug Labeling
New FDA AI Tool Identifies AE Changes in Drug Labeling
The FDA has developed an AI tool to help its drug application reviewers and researchers identify changes to adverse event (AE) terms made when a drug’s labeling is updated.
